Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
29.06
+0.86 (3.05%)
At close: Apr 14, 2026, 4:00 PM EDT
29.46
+0.40 (1.38%)
Pre-market: Apr 15, 2026, 5:41 AM EDT

Genmab Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
17,86319,78513,81321,03827,95525,998
Market Cap Growth
34.00%43.23%-34.34%-24.74%7.52%-2.45%
Enterprise Value
21,59023,20510,99016,97324,81723,096
Last Close Price
29.0630.8020.8731.8442.3839.56
PE Ratio
18.5520.0411.9133.2435.6158.18
PS Ratio
4.805.324.438.8013.3920.20
PB Ratio
3.063.382.694.507.127.66
P/TBV Ratio
3.113.302.634.487.127.70
P/FCF Ratio
15.5517.2212.5720.6754.0286.03
P/OCF Ratio
15.0616.6812.2719.6449.6576.30
EV/Sales Ratio
5.806.243.527.1011.8917.94
EV/EBITDA Ratio
16.7420.4310.6520.8326.0147.18
EV/EBIT Ratio
17.2721.7911.3121.9927.5151.14
EV/FCF Ratio
18.7920.2010.0016.6747.9676.43
Debt / Equity Ratio
0.880.880.030.020.020.02
Debt / EBITDA Ratio
4.784.780.140.140.090.13
Debt / FCF Ratio
4.724.720.130.110.170.22
Net Debt / Equity Ratio
0.640.64-0.55-0.87-0.80-0.85
Net Debt / EBITDA Ratio
3.273.27-2.72-4.97-3.28-5.91
Net Debt / FCF Ratio
3.233.23-2.56-3.98-6.04-9.57
Asset Turnover
0.390.390.540.500.520.36
Inventory Turnover
17.6317.6316.407.82--
Quick Ratio
2.022.025.2413.3415.5114.52
Current Ratio
2.022.025.2413.3415.4814.50
Return on Equity (ROE)
17.53%17.53%23.08%14.66%21.44%13.84%
Return on Assets (ROA)
8.83%8.83%14.27%12.47%17.48%9.42%
Return on Invested Capital (ROIC)
13.05%13.05%45.16%75.20%97.41%56.01%
Return on Capital Employed (ROCE)
12.44%12.44%18.47%17.29%23.74%13.30%
Earnings Yield
5.39%4.99%8.40%3.01%2.81%1.72%
FCF Yield
6.43%5.81%7.96%4.84%1.85%1.16%
Buyback Yield / Dilution
3.04%3.04%1.88%0.17%0.05%-0.24%
Total Shareholder Return
3.04%3.04%1.88%0.17%0.05%-0.24%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q